PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home Covid-19 test capabilities
PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing capabilities. Enabled through a collaboration with PWNHealth